ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 83 filers reported holding ORCHARD THERAPEUTICS PLC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $2,645,000 | -76.4% | 440,801 | -70.4% | 0.03% | -81.6% |
| Q1 2020 | $11,207,000 | -37.7% | 1,488,314 | +13.7% | 0.15% | -8.1% |
| Q4 2019 | $17,993,000 | +81.9% | 1,308,597 | +57.2% | 0.16% | +61.6% |
| Q3 2019 | $9,889,000 | -1.0% | 832,429 | +16.6% | 0.10% | +3.1% |
| Q2 2019 | $9,986,000 | -21.6% | 713,829 | +0.2% | 0.10% | -20.0% |
| Q1 2019 | $12,741,000 | +26.0% | 712,591 | +10.9% | 0.12% | +13.2% |
| Q4 2018 | $10,110,000 | – | 642,741 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |